Abstract:The NF-κB (nuclear factor κ-light-chain-enhancer of activated B cells) transcription factor family is a pleiotropic regulator of many cellular signaling pathways, providing a mechanism for the cells in response to a wide variety of stimuli linking to inflammation. The stimulated cells will be regulated by not only the canonical but also non-canonical NF-κB pathways. To initiate both of these pathways, IκB-degradation triggers NF-κB release and the nuclear translocated-heterodimer (or homodimer) can associate with the κB sites of promoter to regulate the gene transcriptions. NF-κB ubiquitously expresses in neurons and the constitutive NF-κB activation is associated with processing of neuronal information. NF-κB can regulate the transcription of genes such as chemokines, cytokines, proinflammatory enzymes, adhesion molecules, proinflammatory transcription factors, and other factors to modulate the neuronal survival. In neuronal insult, NF-κB constitutively active in neuron cell bodies can protect neurons against different injuries and regulate the neuronal inflammatory reactions. Besides neurons, NF-κB transcription factors are abundant in glial cells and cerebral blood vessels and the diverse functions of NF-κB also regulate the inflammatory reaction around the neuronal environment. NF-κB transcription factors are abundant in the brain and exhibit diverse functions. Several central nerve system (CNS) diseases are linked to NF-κB activated by inflammatory mediators. The RelA and c-Rel expression produce opposite effects on neuronal survival. Importantly, c-Rel expression in CNS plays a critical role in anti-apoptosis and reduces the age-related behaviors. Moreover, the different subunits of NF-κB dimer formation can modulate the neuroninflammation, neuronal protection, or neurotoxicity. The diverse functions of NF-κB depend on the subunits of the NF-κB dimer-formation which enable us to develop a therapeutic approach to neuroinflammation based on a new concept of inflammation as a strategic tool in neuronal cells. However, the detail role of NF-κB in neuroinflammation, remains to be clarified. In the present article, we provide an updated review of the current state of our knowledge about relationship between NF-κB and neuroinflammation.

Possible new role for NF-κB in the resolution of inflammation

Anti-inflammatory lipid mediators and insights into the resolution of inflammation

[Research Progress on Receptor Interacting Proteins in Inflammation].

NF-κB signaling in inflammation

NF‐κB signaling in inflammation and cancer

NF-κB Signaling in Macrophages: Dynamics, Crosstalk, and Signal Integration

NF-κB in biology and targeted therapy: new insights and translational implications

NF-kappaB Signaling Pathways in Neurological Inflammation: A Mini Review

The non-canonical NF-κB pathway in immunity and inflammation

NF-κB in monocytes and macrophages – an inflammatory master regulator in multitalented immune cells

Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study

The Role of NF-κB in Physiological Bone Development and Inflammatory Bone Diseases: Is NF-κB Inhibition “Killing Two Birds with One Stone”?

Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators

The Regulation of NF-κB Subunits by Phosphorylation

Nrf2 Signaling Pathway: Pivotal Roles in Inflammation.

NF-κB: At the Borders of Autoimmunity and Inflammation

An Essential Role for NF-κB in Preventing TNF-α-Induced Cell Death

Neutrophils induce macrophage anti-inflammatory reprogramming by suppressing NF-κB activation

NF-κB Signaling and Inflammation—Drug Repurposing to Treat Inflammatory Disorders?

Roles of Resolvins in Chronic Inflammatory Response

Nuclear Factor Kappa B Signaling Complexes in Acute Inflammation